Vincent JL, Baron JF, Reinhart K, Gattinoni L, Thijs L, Webb A, et al. ABC (Anemia and Blood Transfusion in Critical Care) Investigators. Anemia and blood transfusion in critically ill patients. JAMA 2002;288:1499–1507.
Hayden SJ, Albert TJ, Watkins TR, Swenson ER. Anemia in critical illness: insights into etiology, consequences, and management. Am J Respir Crit Care Med 2012;185:1049–1057.
Chant C, Wilson G, Friedrich JO. Anemia, transfusion, and phlebotomy practices in critically ill patients with prolonged ICU length of stay: a cohort study. Crit Care 2006;10:R140.
Sihler KC, Raghavendran K, Westerman M, Ye W, Napolitano LM. Hepcidin in trauma: linking injury, inflammation, and anemia. J Trauma 2010;69:831–837.
Girelli D, Nemeth E, Swinkels DW. Hepcidin in the diagnosis of iron disorders. Blood 2016;127:2809–2813.
Jelkmann I, Jelkmann W. Impact of Erythropoietin on Intensive Care Unit Patients. Transfus Med Hemother. 2013;40:310–318.
Von Ahsen N, Muller C, Serke S, Frei U, Eckardt KU. Important role of nondiagnostic blood loss and blunted erythropoietic response in the anemia of medical intensive care patients, Crit Care Med 1999;27:2630–2639.
Rodriguez RM, Corwin HL, Gettinger A, Corwin MJ, Gubler D, Pearl RG. Nutritional deficiencies and blunted erythropoietin response as causes of the anemia of critical illness. J Crit Care 2001;16:36–41.
Garratty G. Immune hemolytic anemia caused by drugs. Expert Opin Drug Saf. 2012;11:635–642.
Vincent JL, Sakr Y, Sprung C, Harboe S, Damas P. Are blood transfusion associated with greater mortality rates? Results of the sepsis occurrence in acutely ill patients (SOAP) study. Anesthesiology 2008;108:31–39.
Hébert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care investigators, Canadian Critical Care Trials Group. N Engl J Med 1999;340:409–417.
Pieracci FM, Henderson P, Rodney JR, Holena DN, Genisca A, Ip I, et al. Randomized, double-blind, placebo controlled trial of effects of enteral iron supplementation on anemia and risk of infection during surgical critical illness. Surg Infect (Larchmt) 2009;10:9–19.
Pieracci FM, Stovall RT, Jaouen B, Rodil M, Cappa A, Burlew CC, et al. A multicenter, randomized clinical trial of IV iron supplementation for anemia of traumatic critical illness. Crit Care Med 2014;42:2048–2057.
IRONMAN Investigators, Litton E, Baker S, Erber WN, Farmer S, Ferrier J, et al. Australian and New Zealand Intensive Care Society Clinical Trials Group. Intravenous iron or placebo for anaemia in intensive care: the IRONMAN multicentre randomized blinded trial: a randomized trial of IV iron in critical illness. Intensive Care Med 2016;42:1715–1722.
Corwin HL, Gettinger A, Rodriguez RM, Pearl RG, Gubler KD, Enny C, et al. Efficacy of recombinant human erythropoietin in the critically ill patient: a randomized, double-blind, placebo- controlled trial. Crit Care Med 1999;27:2346–2350.
